Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic
Open Access
- 17 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Family Practice
- Vol. 12 (1), 88
- https://doi.org/10.1186/1471-2296-12-88
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Comparison of Two Different Models of Anticoagulation Management Services with Usual Medical CarePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010
- Shifts in expectations: Evaluating physicians' perceptions as pharmacists become integrated into family practiceJournal of Interprofessional Care, 2009
- Dabigatran versus Warfarin in the Treatment of Acute Venous ThromboembolismNew England Journal of Medicine, 2009
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging StudyBlood, 2008
- Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trialAmerican Heart Journal, 2008
- Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest, 2008
- Management of Chinese patients on warfarin therapy in two models of anticoagulation service – a prospective randomized trialBritish Journal of Clinical Pharmacology, 2006
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005